New Hampshire’s primary election was dominated by voters’ feelings about Donald Trump. But health care remains a concern — and for Democrats, preserving abortion access is a priority.
Category: Biden Administration
KFF Health News’ ‘What the Health?’: The Supreme Court vs. the Bureaucracy
The Supreme Court this week heard oral arguments in a case that could radically alter the way federal agencies — including the Department of Health and Human Services — administer laws passed by Congress. A decision in the case is expected this spring or summer. Meanwhile, the Biden administration is struggling over whether to ban menthol cigarettes — a move that could improve public health but also alienate Black voters, the biggest menthol users. Joanne Kenen of Johns Hopkins University and Politico Magazine, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Darius Tahir, who reported and wrote the latest KFF Health News-NPR “Bill of the Month” feature about a lengthy fight over a bill for a quick telehealth visit.
KFF Health News’ ‘What the Health?’: All About the (Government) Funding
With days to go until a large chunk of the federal government runs out of money needed to keep it operating, Congress is still struggling to find a compromise spending plan. Meanwhile, the Supreme Court agreed to hear — this year — a case that pits federal requirements for emergency treatment against state abortion bans. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews American Medical Association President Jesse Ehrenfeld about the choppy waters facing the nation’s physicians in 2024.
KFF Health News’ ‘What the Health?’: Democrats See Opportunity in GOP Threats to Repeal Health Law
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.